ROHTO PHARMACEUTICAL CO.,LTD.JP:4527

Market cap

¥709,480m

P/E ratio

41.4

Summary Income statement Balance sheet Cash flow

	Mar 31, 2010	Mar 31, 2011	Mar 31, 2012	Mar 31, 2013	Mar 31, 2014	Mar 31, 2015	Mar 31, 2016	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023
Net sales	113,429	115,472	120,292	129,146	143,822	151,774	167,016	154,599	171,742	183,582	188,327	181,287	199,646	238,664
Ordinary profit (loss)	12,770	13,293	13,684	14,730	17,100	14,098	15,339	15,964	18,849	18,970	22,735	23,910	29,084	35,568
Profit (loss) attributable to owners of parent
Comprehensive income
Basic earnings (loss) per share
Diluted earnings per share
Net cash provided by (used in) operating activities
Net cash provided by (used in) investing activities
Net cash provided by (used in) financing activities